Clinical Trial Update: Testosterone and Pain Sensitivity [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the relationship between testosterone and pain sensitivity, conducted by Johns Hopkins University, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: Johns Hopkins University | Conditions: Low Testosterone, Hypogonadism | Phase 4 | Status: WITHDRAWN